Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
393
-
Total 13F shares, excl. options
-
18,655,055
-
Shares change
-
+1,881,661
-
Total reported value, excl. options
-
$6,406,249,888
-
Value change
-
+$717,963,899
-
Put/Call ratio
-
249%
-
Number of buys
-
201
-
Number of sells
-
-148
-
Price
-
$343.43
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2015
484 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q1 2015.
ISHARES TR - ISHARES BIOTECH (IBB) has 393 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,655,055 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (2,921,090 shares), MORGAN STANLEY (2,032,837 shares), BNP PARIBAS ARBITRAGE, SA (1,704,451 shares), JPMORGAN CHASE & CO (1,553,623 shares), BANK OF AMERICA CORP /DE/ (1,517,488 shares), CITIGROUP INC (1,473,831 shares), UBS Group AG (816,255 shares), Beaumont Financial Partners, LLC (451,189 shares), MANAGED ACCOUNT ADVISORS LLC (413,160 shares), and CHURCHILL MANAGEMENT Corp (352,024 shares).
This table shows the top 393 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.